Article Text

Download PDFPDF
Comparative study of 99mTc-ECD and99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis
  1. Terence J O’Briena,
  2. Benjamin H Brinkmannb,
  3. Brian P Mullanc,
  4. Elson L Soa,
  5. Mary F Hauserc,
  6. Michael K O’Connorc,
  7. Joseph Hungc,
  8. Clifford R Jackc
  1. aDepartment of Neurology, bDepartment of Biomedical Imaging, cDepartment of Diagnostic Imaging, Mayo Clinic, Rochester, MN, USA
  1. Dr E L So, Department of Neurology, Section of Electroencephalography, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA. Telephone 001 507 284 8307; fax 001 507 284 8686.

Abstract

OBJECTIVES Most studies that clinically validated peri-ictal SPECT in intractable partial epilepsy had used technetium-99m-hexamethylpropylene amine oxime (99mTc-HMPAO or 99mTc-exametazime) as the radiopharmaceutical. Because of some theoretical advantages, technetium-99m-ethyl cysteinate diethylester (99mTc-ECD or99mTc-bicisate) is increasingly being used instead. This study compares unstabilised 99mTc-HMPAO and99mTc-ECD in the performance of peri-ictal SPECT in partial epilepsy.

METHODS The injection timing and localisation rates in 49 consecutive patients with partial epilepsy who had peri-ictal injections with unstabilised99mTc-HMPAO were compared with 49 consecutive patients who had peri-ictal injections with 99mTc-ECD. Quantitative cortical/subcortical and cortical/extracerebral uptake ratios were also compared. Subtraction SPECT coregistered to MRI (SISCOM) was performed in patients whose interictal SPECTS were available.

RESULTS In the99mTc-ECD patients, the latency from seizure commencement to injection was shorter (median 34 v 80 seconds, p<0.0001) and there was a lower rate of postictal injections (16.3% v 57.1%, p<0.0001). The cortical/extracerebral and cortical/subcortical uptake ratios were greater in the 99mTc-ECD images (median 5.0v 3.6, and 2.5 v2.2 respectively; both p<0.005), but the relative peri-ictal increase in uptake in the cortical focus did not differ significantly (median 37.0% v 37.0%; p>0.05). Blinded review of the SISCOM images were localising in a higher proportion of the99mTc-ECD patients (40/45 (88.9%)v 25/37 (67.6%), p<0.05), and had a better concordance with EEG, MRI, and with the discharge diagnosis.

CONCLUSION 99mTc-ECD compares favourably with unstabilised 99mTc-HMPAO as a radiopharmaceutical for peri-ictal SPECT studies. Its use results in earlier injections and less frequent postictal injections than unstabilised 99mTc-HMPAO, thereby enhancing the sensitivity and the specificity of peri-ictal SPECT for the localisation of intractable partial epilepsy.

  • Ictal SPECT
  • 99mTc-ECD
  • 99mTc-HMPAO

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes